Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis

NCT07521332 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

220

Enrollment

OTHER

Sponsor class

Conditions

Cirrhosis
Esophageal and Gastric Varices
Ascites
Hepatic Encephalopathy
Portal Vein Thrombosis
Portal Hypertension

Interventions

DRUG: Apixaban
DRUG: Carvedilol
DRUG: Placebo

Sponsor

Asian Institute Of Medical Sciences